A journal has accepted the sixth retraction of a paper co-authored by Silvia Bulfone-Paus, the Research Centre Borstel announced late last week. Borstel has been investigating allegations that two of Bulfone-Paus’s former postdocs manipulated images.
We’ve had two questions since learning of the fraud case involving Naoki Mori: Who discovered the manipulations? And how?
We now have answers. We recently received an e-mail from a researcher who specializes in Mori’s field — cancer viruses — and who claims to have been a reviewer of a paper he submitted early last year to a journal in his field. (We’re obscuring some details to maintain our source’s anonymity.)
The retraction last week of a commentary in the Journal of the National Cancer Institute (JNCI) looks like a nice — and very quick — example of self-correction in science.
About two weeks ago, we reported on the first retraction of a paper co-authored by Silvia Bulfone-Paus, whose work at her Research Center Borstel lab is being investigated for misconduct. On Friday, Borstel announced that journals had accepted four more retractions of papers by Bulfone-Paus’s group.
Salon today retracted a controversial 2005 story by Robert F. Kennedy, Jr. about an alleged link between autism and thimerosal, the mercury-based preservative formerly used in vaccines.
Late last month we wrote about a handful of retractions involving Naoki Mori, a promising Japanese cancer researcher who appears to have built a CV with the help of fabricated evidence.
The fraud earned Mori a 10-year publishing ban from the American Society of Microbiology, which publishes Infection and Immunity. There were two other retractions in Blood, from the American Society of Hematology.
A quick post this Sunday morning to draw your attention to two must-read items for anyone interested in the Anil Potti case or in how one goes about checking data. (A second paper by Potti et al was officially retracted on Friday.)
was one of 110 Duke patients enrolled in three clinical trials based on the research of Dr. Anil Potti, who resigned in November as an associate professor at Duke.
This is the second retraction of a paper by Potti, who resigned from his post at Duke in November in the midst of an investigation into scientific misconduct. The first retraction was in the Journal of Clinical Oncology.